AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 11 mins

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
167.35-0.10 (-0.06%)
As of 11:49AM EDT. Market open.
People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close167.45
Open167.48
Bid167.43 x 300
Ask167.48 x 100
Day's Range166.41 - 167.98
52 Week Range133.64 - 184.21
Volume1,410,417
Avg. Volume3,942,191
Market Cap123.25B
Beta1.76
PE Ratio (TTM)16.34
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.76%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • How This Company Is Taking on Amgen
    Motley Fool3 hours ago

    How This Company Is Taking on Amgen

    The Medicines Company is developing a new drug that could give Amgen's Repatha a run for its money in lowering bad cholesterol levels.

  • American City Business Journals20 hours ago

    Biotech giant plans $25M Tampa investment, 450 jobs

    Amgen Inc. will open a capability center in Tampa, creating hundreds of high-skill jobs. Amgen (AMGN), a biotechnology firm headquartered in Thousand Oaks, California, will invest $25 million in the 136,000-square-foot center, which will occupy four floors of Corporate Center One at 2202 N. Westshore Blvd. The center is expected to open in October and will employ 450 people by the end of 2018, a press release from the Tampa Hillsborough Economic Development Corp. said. Amgen visited several U.S. cities before deciding to locate in Tampa, said Kristen Davis, a spokeswoman for Amgen.

  • Zacksyesterday

    Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen

    Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen